FOXO Technologies Inc. (NYSEAMERICAN:FOXO) Short Interest Update

FOXO Technologies Inc. (NYSEAMERICAN:FOXO) was the target of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 1,890,000 shares, a growth of 111.0% from the February 13th total of 895,600 shares. Currently, 6.7% of the shares of the company are sold short. Based on an average daily trading volume, of 6,960,000 shares, the short-interest ratio is presently 0.3 days.

FOXO Technologies Price Performance

Shares of FOXO Technologies stock traded down $0.00 during trading on Friday, reaching $0.15. The company’s stock had a trading volume of 544,375 shares, compared to its average volume of 8,299,908. The business’s 50 day simple moving average is $0.28. FOXO Technologies has a 12-month low of $0.13 and a 12-month high of $1.30.

Hedge Funds Weigh In On FOXO Technologies

An institutional investor recently bought a new position in FOXO Technologies stock. Jane Street Group LLC acquired a new position in shares of FOXO Technologies Inc. (NYSEAMERICAN:FOXO) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 117,047 shares of the company’s stock, valued at approximately $34,000. Jane Street Group LLC owned about 0.67% of FOXO Technologies at the end of the most recent reporting period. 44.89% of the stock is currently owned by institutional investors.

About FOXO Technologies

FOXO Technologies Inc engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging.